Navigation Links
Monarc™ Subfascial Hammock

ProductsMonarc™ Subfascial Hammock
Company AMS
Item Monarc™ Subfascial Hammock
Features 
  • The Needles: The Monarc™ Subfascial Hammock is a single-use procedure kit that includes two stainless steel, helical needles each specifically designed for right-side/left-side.
  • The needles are designed to move away from the obturator canal, avoid the retropubic space and minimize blind needle passage.
  • The Mesh: Knitted, polypropylene Type I mesh offers tissue fixation without suturing and large pores to facilitate tissue integration.
  • The patented tensioning suture maintains mesh integrity during placement and allows for intra and immediate post-operative tensioning while reducing sling deformation.
Description The Monarc Subfascial Hammock™ is a minimally invasive treatment option for female patients suffering from stress urinary incontinence (SUI). The Monarc treats SUI by supporting the urethra during abdominal stress events, such as sneezing, coughing or laughing. Monarc's outside-to-in transobturator approach avoids the retropubic space.Monarc's transobturator approach and knitted, polypropylene mesh create a hammock-shaped midurethral sling. It helps maintain continence by supporting the midurethra during times of increased abdominal pressure.
Info AMS
Customer Service: (800) 328-3881
Web site: http://www.americanmedicalsystems.com

Related medicine products :

1. BioArc™ TO Subfascial Hammock
Used for catheter positioning and exchange in endourological procedures. The increased inner diameter of the wire guide coils allows utilization of an extra heavy duty mandril with a smooth transitio
Supplied sterile in peel-open packages. Intended for one-time use.
Supplied sterile in peel-open packages. Intended for one-time use.
Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products:
(Date:8/8/2008)...gnosis, less successful surgery, pair of studies f... -- The standard screening test for prostate cance...more vulnerable to the disease, and surgery is les...tudies found. , "Obese men are more likely to b...," said Dr. Stephen Freedland, an associate profes...
(Date:8/8/2008)...A, Md., Aug. 8 /PRNewswire-FirstCall/ -- Hanger Or...nnounce that Moody,s Investors,Service revised its...itive",from "stable." Moody,s also affirmed Hanger...re pleased with the outlook change from Moody,s as...ten quarters," remarked George McHenry,Hanger,s C...
(Date:8/7/2008)...ls of testosterone may be a key factor in spreadin... findings could help explain why males in a popula...ansmit disease., , Previous research has linked...tem suppression. Studies have shown that males, co...e, and account for a larger share of disease trans...
(Date:8/7/2008)...urgh Tissue Engineering Initiative Marks 12th Year...p, PITTSBURGH, Aug. 7 /PRNewswire/ -- Twenty-four...ties, primarily across southwestern Pennsylvania,a...2th annual Summer,Internship Program of the Pittsb...l of the program is to expose greatly increased nu...
Breaking Medicine News(10 mins):Health News:Obese Men Face Twin Threat From Prostate Cancer 2Health News:Testosterone key to disease transmission 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 3
...nticipation of a fearful situation can play an imp... the University of Wisconsin-Madison, while conduc...f memory have come up with the findings that the v...l situation can stir up two memory-forming regions...
...atients taking newer blood pressure drugs have a d... an analysis of the biggest clinical trial in Euro...eople on newer medicines developed diabetes as aga...ugs. The study involved 19,000 people. The study ...
... study in the September issue of Archives of Pedia...ves journals says that hospitals must be prepared ...f and equipment to treat injured and noninjured ch...he report is based on the experience of training a...
...olgate-Palmolive (India) Limited, the market leade...tal Association (IDA) today announced that Septemb... in its third year, Oral Health Month (OHM) is an ...gn in India to establish and promote the importanc...
Other Medicine News:Health News:Anticipation Could Have An Intense Effect On Memory 2Health News:Anticipation Could Have An Intense Effect On Memory 3Health News:Military Hospitals Need To Be Prepared To Treat Children 2Health News:Striving to Make India Free from Tooth Decay 2
(Date:8/7/2008)...ve Decision to Expand its Proprietary ...rland, Aug. 7 /- ESBATech AG, a leadi...day announced that the,company has raised an addit...ries B venture round to expand its development pip...ticipated in this round including SV Life,Sciences...
(Date:8/6/2008)...manently implanted into the heart works,with an el...s patient,s,pulmonary artery pressure, CHICAGO, A...ortness of,breath are common symptoms that send te...o U.S. hospitals each month. Cardiologists at the ...orial Hospital may be able to,curb such visits for...
(Date:8/6/2008)...re-FirstCall/ -- GlaxoSmithKline (NYSE:,GSK) (GSK)...4,600 patients,in 54 clinical studies showed no in...ith the anti-HIV medication abacavir. GSK conducte...rtaken by the D:A:D cohort had found an,unexpected...ntiretroviral,therapy (HAART) regimens containing ...
(Date:8/6/2008)...s $15 million payment from collaborator ...., Aug. 6 /- Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...l Phase 3 clinical trial that is evaluating otelix... a result of the initiation of,patient dosing in D...
Breaking Medicine Technology:ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing 2ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing 3New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorial's Bluhm Cardiovascular Institute 2New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorial's Bluhm Cardiovascular Institute 3Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 2Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 3Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 4Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 5Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 2Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 3Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 4Cipher appoints Stefan Aigner to board of directors 7671 1Cipher appoints Stefan Aigner to board of directors 7671 2Cipher appoints Stefan Aigner to board of directors 7671 3Wyeth Receives Honors at the 2007 Scrip Awards 7667 1Wyeth Receives Honors at the 2007 Scrip Awards 7667 2Wyeth Receives Honors at the 2007 Scrip Awards 7667 3Wyeth Receives Honors at the 2007 Scrip Awards 7667 4Wyeth Receives Honors at the 2007 Scrip Awards 7667 5Dads break bones of children more often than moms 7663 1Dads break bones of children more often than moms 7663 2Scientists identify gene that influences alcohol consumption 7659 1Scientists identify gene that influences alcohol consumption 7659 2
...al protection,against infection with other cancer-...PRNewswire-FirstCall/ -- The,GlaxoSmithKline cervi...rated 100 percent efficacy in preventing precancer...irus types 16 and 18,for up to 5.5 years in an ext... today at the American Association for Cancer,Rese...
...st-Ever IVF Trial,in US, RANCHO MIRAGE, Calif., Ap...es evaluating Ferring Pharmaceuticals, ENDOMETRIN(...ment for luteal phase,support (supplementation to ...ges of pregnancy) in assisted reproductive,technol...ing of the,Pacific Coast Reproductive Society in R...
Other Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5